Purpose: To assess the effect of topical taprenepag isopropyl on each layer of the cornea by confocal microscopy.
Methods: Thirty-two ocular hypertensive or glaucoma patients were randomized into a 2-period, crossover study of 14 days of 0.1% taprenepag alone and in unfixed combination with 0.